
Sintx Technologies SINT
$ 2.38
0.42%
Annual report 2025
added 03-20-2026
Sintx Technologies Interest Expense 2011-2026 | SINT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Sintx Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 K | 39 K | 17 K | 382 K | 4 K | 282 K | 48 K | 83 K | - | - | -14 K | 3.65 M | 1.85 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.65 M | -14 K | 579 K |
Quarterly Interest Expense Sintx Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 2 K | 1 K | - | 1 K | 27 K | 6 K | - | - | -3 K | 8 K | - | 8 K | 162 K | - | - | -1 K | 130 K | 12 K | - | 200 K | - | - | - | 48 K | 48 K | - | - | 1 K | 3 K | 2 K | - | 1 K | -4 K | - | - | 5 K | -1 K | - | - | 1.15 M | 1.13 M | 1.1 M | - | 1.11 M | 554 K | 530 K | - | 453 K | 445 K | 447 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.15 M | -4 K | 244 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.13 | -1.39 % | $ 1.29 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.44 | 3.81 % | $ 410 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
78 K | $ 25.21 | -1.6 % | $ 213 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.49 | 4.49 % | $ 131 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 46.15 | -15.91 % | $ 1.36 B | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.25 | 0.63 % | $ 319 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 57.82 | -2.12 % | $ 3.15 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 169.07 | -1.35 % | $ 11.9 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.05 | 1.71 % | $ 377 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.96 | 2.37 % | $ 1.05 B | ||
|
Globus Medical
GMED
|
3.41 M | $ 91.09 | 0.54 % | $ 12.3 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.07 | 0.45 % | $ 1.12 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 86.83 | 3.36 % | $ 3.02 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 96.34 | -0.76 % | $ 3.27 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 19.25 | -3.12 % | $ 1.31 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 82.79 | -0.65 % | $ 48.4 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.51 | -0.9 % | $ 65.9 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.26 | -5.26 % | $ 51.3 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.71 | 2.77 % | $ 548 M | ||
|
Myomo
MYO
|
-668 K | $ 0.85 | -1.1 % | $ 35.6 M |